MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01547481|
Recruitment Status : Completed
First Posted : March 7, 2012
Last Update Posted : May 17, 2018
|Condition or disease|
|Movement Disorders (Incl Parkinsonism) Tremor Familial Essential, 1 REM Sleep Behavior Disorder|
|Study Type :||Observational|
|Actual Enrollment :||50 participants|
|Official Title:||Statistical Mapping of the Brain in Progressive Supranuclear Palsy, Essential Tremor, Parkinson Disease, Parkinsonism, and REM Behavior Disorder|
|Study Start Date :||December 2011|
|Actual Primary Completion Date :||December 31, 2015|
|Actual Study Completion Date :||December 31, 2015|
Parkinson's Disease Cohort
Individuals Diagnosed with Parkinson's Disease
Essential Tremor cohort
Individuals Diagnosed with Essential Tremor
Rapid Eye Movement Disorder Cohort
Individuals Diagnosed with Rapid-Eye Movement Behavior Disorder (RBD). Eligible individuals will have been diagnosed with RBD based on a sleep study prior to entering the study. This study does not pay for or support a sleep study.
Healthy Control group
Individuals are healthy, without a known neurologic disease.
Progressive Supranuclear Palsy Cohort
Individuals diagnosed with Progressive Supranuclear Palsy (PSP).
Parkinsonism - Undifferentiated
Individuals with any form of Parkinsonism, not meeting any of the above cohorts.
- fMRI compared between cohorts [ Time Frame: one time at initial visit ]Studying resting brain activity between healthy adults, participants with Parkinson's and participants with REM Behavior Disorder.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01547481
|United States, Alabama|
|University of Alabama at Birmingham|
|Birmingham, Alabama, United States, 35294|
|Principal Investigator:||Frank Skidmore, MD||University of Alabama at Birmingham|